Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2014
06/19/2014US20140171495 Stable pharmaceutical formulation of cabazitaxel
06/19/2014US20140171490 Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
06/19/2014US20140171487 RNAi-MEDIATED INHIBITION OF PHOSPHODIESTERASE TYPE 4 FOR TREATMENT OF cAMP-RELATED OCULAR DISORDERS
06/19/2014US20140171482 Nanotubes as Carriers of Nucleic Acids into Cells
06/19/2014US20140171481 Solid compositions
06/19/2014US20140171479 Melatonin treatment methods
06/19/2014US20140171478 Controlled-release melatonin compositions and related methods
06/19/2014US20140171475 Animal ectoparasite-controlling agent
06/19/2014US20140171472 Pyridoxamine for the Treatment of Diabetic Kidney Disease
06/19/2014US20140171467 Inhibitors of ncca-atp channels for therapy
06/19/2014US20140171465 Methods For Increasing Reticulocyte Hemoglobin Content
06/19/2014US20140171464 Pharmaceutical composition containing diamine derivative
06/19/2014US20140171463 Treatment of progressive neurodegenerative disease with ibudilast
06/19/2014US20140171462 4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2h-pyran-4-yl)-1 h-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor
06/19/2014US20140171460 Methods and compositions for treatment of epithelial wounds
06/19/2014US20140171459 Methods for treating pruritus
06/19/2014US20140171458 Intranasal naltrexone
06/19/2014US20140171457 Implantable Polymeric Device for Sustained Release of Buprenorphine
06/19/2014US20140171456 FUSED TRICYCLIC COMPOUNDS AS mTOR INHIBITORS
06/19/2014US20140171455 Reduction of Microglia-Mediated Neurotoxicity by Kv1.3 Inhibition
06/19/2014US20140171452 Methods for treating depression, neurodegeneration, inhibiting amyloid beta deposition, delaying senescence, and extending life spans with heterocyclic compounds
06/19/2014US20140171448 Use of nicotinic acetylcholine receptor alpha 7 activators
06/19/2014US20140171447 Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity
06/19/2014US20140171445 Treatment and prevention of diseases mediated by microorganisms via drug-mediated manipulation of the eicosanoid balance
06/19/2014US20140171444 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof
06/19/2014US20140171440 Methods of Increasing Liver Proliferation
06/19/2014US20140171439 Inhibitors Of Histone Deacetylase
06/19/2014US20140171436 Treatment of antifolate neurotoxicity
06/19/2014US20140171435 Chemical Compounds
06/19/2014US20140171434 Substituted imidazopyridines and imidazopyridazines and the use thereof
06/19/2014US20140171431 Azole heterocyclic compound, preparation method, pharmaceutical composition and use
06/19/2014US20140171424 Hypertension and hyperuricemia
06/19/2014US20140171420 Diazole lactams
06/19/2014US20140171417 Tricyclic compounds
06/19/2014US20140171415 Funny current (if) inhibitors for use in a method of treating and preventing heart disease in canine
06/19/2014US20140171412 Tricyclic compounds
06/19/2014US20140171411 (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
06/19/2014US20140171408 Azabenzothiazole compounds, compositions and methods of use
06/19/2014US20140171407 1,7-diazacarbazoles and methods of use
06/19/2014US20140171404 Autotaxin inhibitors
06/19/2014US20140171403 Autotaxin inhibitors
06/19/2014US20140171401 Novel pharmaceutical formulation of cefixime for enhanced bioavailability
06/19/2014US20140171399 Topical skin care composition
06/19/2014US20140171398 Formoterol/steroid bronchodilating compositions and methods of use thereof
06/19/2014US20140171397 Biphenyl compounds useful as muscarinic receptor antagonists
06/19/2014US20140171396 Combination Hormone Replacement Therapy (HRT) and Melatonin to Prevent and Treat Mammary Cancer
06/19/2014US20140171395 Tunable Nitric Oxide-Releasing Macromolecules Having Multiple Nitric Oxide Donor Structures
06/19/2014US20140171391 Method for treating sepsis in patients with albumin, cholesterol and hdl levels above minimum thresholds
06/19/2014US20140171390 Beta-lactamase inhibitors
06/19/2014US20140171389 Methods for treating cancer
06/19/2014US20140171387 Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity
06/19/2014US20140171386 Method and Composition to Reduce Diarrhea in a Companion Animal
06/19/2014US20140171384 Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine
06/19/2014US20140171383 Central administration of stable formulations of therapeutic agents for cns conditions
06/19/2014US20140171382 Methods for identifying an increased risk of anthracycline-related cardiotoxicity
06/19/2014US20140171380 Screening Assays Using Stem Cells and Stem Cell-Derived Neurons from Mouse Models of Alzheimer's Disease
06/19/2014US20140171374 Use of a truncated eif-5a1 polynucleotide to induce apoptosis in cancer cells
06/19/2014US20140171372 Treatments for Alzheimer's disease
06/19/2014US20140171363 Bicyclic acetyl-coa carboxylase inhibitors and uses thereof
06/19/2014US20140171359 Diagnosis of respiratory tract infectious diseases using urine specimens
06/19/2014US20140171358 Antimicrobial compositions comprising dgla and neomycin sulfate and methods of use thereof
06/19/2014US20140171313 Pesticidal compositions and processes related thereto
06/19/2014US20140171311 Pesticidal compositions and processes related thereto
06/19/2014US20140171310 Pesticidal compositions and processes related thereto
06/19/2014US20140171308 Pesticidal compositions and processes related thereto
06/19/2014US20140170252 Milk yield and/or milk quality improving agent, perinatal disease preventive or therapeutic agent, and reproductivity improving agent for ruminant
06/19/2014US20140170250 Pharmaceutical compositions and method for inhibiting angiogenesis
06/19/2014US20140170247 Emulsion of Carotenoids and Ocular Antioxidants
06/19/2014US20140170244 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
06/19/2014US20140170243 Substituted chroman derivatives, medicaments and use in therapy
06/19/2014US20140170240 Phosphoramidate Alkylator Prodrugs
06/19/2014US20140170236 Use of phosphoric acid
06/19/2014US20140170234 Compositions and improved soft tissue replacement methods
06/19/2014US20140170233 Natural feed mixture for breeding domesticated water birds
06/19/2014US20140170231 Pain relief compositions and methods
06/19/2014US20140170228 Combination therapy methods for treating proliferative diseases
06/19/2014US20140170227 Method for Making Nanolipidic Particles
06/19/2014US20140170226 Method for Making Nanolipidic Particles
06/19/2014US20140170222 Xanthophyll compositions and methods of use
06/19/2014US20140170221 Methods and compositions for localized delivery of agents to virally infected cells and tissues
06/19/2014US20140170220 Multimodal particulate formulations
06/19/2014US20140170219 Composition and method for treating hpv
06/19/2014US20140170217 Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
06/19/2014US20140170216 Bupropion hydrobromide polymorphs
06/19/2014US20140170215 Orally disintegrating tablets and methods of manufacture
06/19/2014US20140170213 Capsule formulation comprising montelukast and levocetirizine
06/19/2014US20140170211 Compositions and methods for treating traumatic brain injury
06/19/2014US20140170210 Methods for treating immunosuppression
06/19/2014US20140170209 Pharmaceutical invention of tapentadol
06/19/2014US20140170208 Transdermal patch formulation
06/19/2014US20140170206 Composition for the transdermal delivery of fentanyl
06/19/2014US20140170205 Ropinirole-containing patch and package thereof
06/19/2014US20140170201 Uniform field magnetization and targeting of therapeutic formulations
06/19/2014US20140170197 Polymeric delivery systems for active agents
06/19/2014US20140170195 Anhydrous Powder-to-Liquid Particles
06/19/2014US20140170175 Novel lipids and compositions for intracellular delivery of biologically active compounds
06/19/2014US20140170165 Methods of generating hyper inos expressing cells and uses thereof
06/19/2014US20140170162 Preservation of the neuromuscular junction (nmj) after traumatic nerve injury
06/19/2014US20140170160 Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap-1) inhibitor
06/19/2014US20140170158 Compositions and methods for treating or preventing lung diseases
1 ... 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 ... 7860